Active Ingredient: CABAZITAXEL
Proprietary Name: CABAZITAXEL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 60MG/6ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N207970
Product Number: 001
Approval Date: Mar 14, 2024
Applicant Holder Full Name: ACTAVIS LLC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
